The latest trading day saw Moderna (MRNA) settling at $69.17, representing a +1.3% change from its previous close.
Moderna stock tumbled again Friday on a series of downgrades and price-target cuts following a "tough update" at its R&D Day.
Moderna stock crashed Thursday after the Covid vaccine maker slashed its R&D budget and issued a light sales view.